Abstract
Background Salvage nivolumab and ipilimumab after prior anti-PD-1/PD-L1 therapy is frequently used off-label for clear cell metastatic renal cell carc......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
